Myndful Wellness is proud to be the exclusive provider of Exomind™ on Colorado’s Western Slope.
Traditional transcranial magnetic stimulation (TMS) protocols typically involve 35 or more treatment sessions, usually scheduled five days per week over several weeks. While effective for many patients, the time commitment, frequent appointments, and cumulative copays can be difficult to manage alongside work, family, and daily responsibilities.
Accelerated TMS Protocol (Self-Pay Option)
At Myndful Wellness, we offer ExoMind® TMS, an accelerated treatment protocol consisting of six treatment sessions lasting under 30 minutes each, completed over a shorter timeframe. Treatments are comfortable, and most patients are able to drive and return to normal activities immediately afterward. Some individuals even fall asleep during treatment, and discomfort or soreness is uncommon.
This accelerated protocol is offered as a self-pay treatment for $3,000, providing predictable pricing without ongoing insurance copays. CareCredit financing is available for patients who prefer to spread the cost into manageable monthly payments.
At this time, Colorado Medicaid does not cover TMS treatment, and Medicare cannot be accepted for TMS services at our practice. Myndful Wellness offers a complimentary 15-minute consultation to discuss symptoms, treatment goals, and whether ExoMind® may be an appropriate option. All treatment decisions are made following a comprehensive psychiatric evaluation and individualized clinical review.
Who May Benefit from ExoMind®
ExoMind® TMS may be helpful for individuals experiencing depression, anxiety, stress-related symptoms, mental fatigue, difficulty with focus, or emotional imbalance. Many people seek ExoMind® when traditional treatments have not provided adequate relief or when they are looking for a non-medication, non-invasive option to support mental wellness. By targeting areas of the brain involved in mood regulation and cognitive functioning, ExoMind® is designed to support improved emotional balance, clarity, and overall well-being. Responses vary, and treatment is always individualized based on a comprehensive clinical evaluation.
EXOMIND stimulates neuroplasticity via upregulation of AMPA and NMDA receptors. Combining it with other methods of inducing neuroplasticity such as Spravato® or ketamine may lead to a synergistic benefit.
